Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 Diabetes
- Conditions
- Parents
- Interventions
- Behavioral: REDCHiP
- Registration Number
- NCT03879642
- Lead Sponsor
- University of Kansas Medical Center
- Brief Summary
Pilot of a novel video-based telemedicine intervention to reduce fear of hypoglycemia in parents of young children with type 1 diabetes.
- Detailed Description
This was a two group randomized controlled study using a wait-list control design. All participating parents had the opportunity to receive 10 video-based telemedicine sessions administered over 13 weeks. Study assessments took place at baseline, post-treatment, and 3 month followup. Study outcomes included parent reported hypoglycemia fear, parenting stress, diabetes distress, and child glycated hemoglobin.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
- Parents of children, between 1-6 years old, with type 1 diabetes for at least 6 months, on either multiple daily injections or an insulin pump, and parents speak English
- Families of children who are older than 6 years-old and or do not have type 1 diabetes; children follow a conventional insulin regimen
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description REDCHiP REDCHiP 10 week video-based telemedicine intervention to reduce parents hypoglycemia fear
- Primary Outcome Measures
Name Time Method Hypoglycemia Fear Survey absolute value at post-treatment (week 14) Hypoglycemia Fear Survey-Parents of Young Children. This is a measure of parents' perceived hypoglycemia fear. Higher scores suggest greater fear (worse outcome). Total possible range: 26-130.
- Secondary Outcome Measures
Name Time Method Child Hemoglobin A1c absolute value at post-treatment (week 14) Child hemoglobin A1c- biological marker of glycemic control